A portfolio company CRO's pay plan is the most underestimated alignment tool in the value creation plan: poorly calibrated, it demotivates a good candidate within 18 months, overpays an average profile for the entire holding period, or locks the fund into an equity structure the CEO won't be able to defend at exit. The decision is never made on a partner's gut instinct carrying over the package from the previous portfolio company, nor on the sole recommendation of a recruiting firm, nor by duplicating the founder CEO's pay plan. It is built on a rigorous portfolio benchmark, an honest read of the portfolio company's stage, consistency across the four components (base, variable, equity, exit bonus), and a clear-eyed projection of what the package will be worth under three exit scenarios.
In PE and VC funds backing B2B scale-ups between €10M and €100M ARR, CRO compensation is the second most structuring capital-allocation decision after the choice of the candidate itself. The Operating Partner plays a distinctive role here: bringing the cross-portfolio benchmark that the CEO cannot rebuild alone, challenging the candidate's requests without stepping into the negotiator's seat, arbitrating between CEO alignment and fund alignment, and documenting the package so it survives investment team turnover on the fund side as well as HR rotation on the portfolio company side. Its added value rests on three irreplaceable contributions. The first is the comparative database spanning 6 to 15 portfolio companies, which lets you place a request in thirty seconds. The second is fluency in equity and exit bonus mechanics, an area where most CEOs are poorly equipped. The third is documentation discipline, which protects the CRO-CEO-fund relationship against the misunderstandings that always surface at exit.
This guide details the Operating Partner method for designing a portfolio company CRO's pay plan: the four components and their target ratios by stage, benchmark figures in France (Series A through Growth), the fundamental difference between PE logic and VC logic on equity, the structure of the annual variable between revenue metrics and strategic metrics, equity mechanics (BSPCE, AGA, phantom shares), the cliff and acceleration at change of control, exit bonus logic indexed to the fund's MOIC, French tax and social specifics, the annual review cadence, the signals of a pay plan going off track and the recovery options, and the mistakes that simultaneously destroy CRO motivation and CEO-OP trust. The angle is that of the capital sponsor, not the portfolio company's HR director nor the candidate in negotiation.
Key Takeaways
- The CRO pay plan is a value creation lever, not a P&L line to optimize: overpaying is costly, underpaying is costlier still because the best profiles leave within 18 months.
- Four components to balance: base salary (€140-220k), annual variable (80-120% of base), equity (0.5% to 2.5% fully diluted), exit bonus indexed to MOIC. None is negotiated in isolation.
- PE vs VC are two different worlds: PE favors phantom equity plus a capped exit bonus, VC favors true equity (BSPCE/AGA) vesting over 4 years. Mixing the two logics creates inconsistencies.
- The variable must never be a commission plan: 50% revenue (ARR, bookings, NRR), 50% strategic (team, process, forecast). A CRO is not a senior AE.
- Well-designed equity means a 1-year cliff, 4-year vesting, double trigger on change of control: any deviation from this standard must be documented and justified to the investment committee.
- Exit bonus equals a percentage of the MOIC uplift above a hurdle: typically 0.3% to 1% of the value created above 2x MOIC, capped at an absolute ceiling to avoid surprises at exit.
- A pay plan is a living document, reviewed annually post-board: refresh grants at 24 months, variable rebalancing as the plan evolves, base revision when ARR milestones are crossed.
"Compensation is the most important communication tool a CEO has. It tells people what you actually value, regardless of what you say in all-hands meetings. Get it wrong, and your best people leave quietly. Get it right, and you unlock extraordinary effort for years."
Jack Welch, Winning (HarperBusiness)
Why the CRO Pay Plan Deserves Dedicated Capital-Level Attention
The CRO pay plan is not a delegable HR topic. It commits the portfolio company's trajectory for 3 to 5 years, it is negotiated against a candidate who is often better prepared than the CEO on compensation mechanics, and it is judged at exit on dimensions nobody weighed at the time of hiring. The OP must get involved to the extent the stakes warrant, without replacing the CEO but without letting the topic be treated as an ordinary package.
The Information Asymmetry Against the Candidate
A senior CRO who changes portfolio companies every 4 to 5 years has negotiated 3 to 5 PE-backed packages over their career. The founder CEO hiring their first CRO has negotiated none from a capital-markets angle. This asymmetry structurally works against the portfolio company. The OP corrects it by bringing the portfolio benchmark, fluency in equity clauses, and the ability to spot atypical requests (asymmetric double trigger, tag-along on exit bonus, early refresh grants). Without this layer, the CEO often signs a package they will regret at exit, without understanding why.
The Cost of a Poorly Calibrated Pay Plan
An undercalibrated pay plan produces a CRO who leaves within 12 to 18 months for a better-built offer, often at a direct competitor. The total cost of replacement runs to €1 to 2M once you add up the search firm, the unproductive ramp, team attrition, and the degraded pipeline during the transition. An overcalibrated pay plan produces a CRO who stays but is no longer motivated by upside because it is already guaranteed: they settle into a comfort zone that caps the portfolio company's performance. In our Revenue Health Score diagnostics conducted with B2B scale-ups, portfolio companies where the CRO pay plan was reworked between day 30 and day 120 outperform those where the initial package was kept without review.
Consistency with the CEO Package
The CRO pay plan must satisfy two constraints at once: motivating the CRO over a holding-period horizon, and staying consistent with the founder CEO's package. If the CRO ends up with equity above 60% of the CEO's, there's a symbolic alignment problem that will show up as internal tension. If the CRO ends up below 25% of the CEO's, they don't have enough skin in the game to commit for the duration. The OP arbitrates this ratio upfront, leaving room for the VP Sales, VP Marketing, and CFO who will follow.
The Capital-Markets Read on Exit
A pay plan is judged at exit, not at hiring. An excellent pay plan at the time of the deal can turn catastrophic if an uncapped exit bonus ends up representing 15% of the value created, or if change-of-control acceleration creates a disproportionate windfall. The OP projects the package under three exit scenarios (downside 1.5x MOIC, base 3x, upside 5x) and rejects any structure that produces a result indefensible to the investment committee under any of the three scenarios.
The Four Components of the CRO Pay Plan
The CRO pay plan in a PE/VC-backed B2B scale-up rests on four components that are designed together, never in a silo. Each component has its own function and a target ratio relative to the others.
Component 1: Base Salary
Base salary covers the CRO's opportunity cost and financial security. It must be sufficient that a senior candidate takes no personal financial risk by joining the portfolio company, but not so high that it neutralizes motivation on the variable and equity. In France, the range for B2B tech scale-ups runs from €140k gross annual for a transition CRO at €5-10M ARR to €220k gross for an optimizer CRO at €50M+ ARR. Above €250k base, the signal is that the candidate is negotiating for security at the expense of alignment.
Component 2: Annual Variable
The annual variable rewards achievement of the annual plan and creates a performance rhythm measured fiscal year after fiscal year. It typically represents 80 to 120% of base, paid quarterly or annually depending on the chosen design. The CRO is not an AE: their variable must not be a commission on individual revenue but a composite bonus mixing revenue metrics (ARR, bookings, NRR) and strategic metrics (hiring, process, coaching, forecast accuracy). A variable that is 100% revenue commission on the CRO produces a leader who chases deals at the expense of building the team.
Component 3: Equity (True or Phantom)
Equity aligns the CRO with value creation over the holding period. It's the component where the gap between VC logic and PE logic is most pronounced. In VC, the CRO typically receives 0.8% to 2.5% of fully diluted capital in the form of BSPCE or AGA, with 4-year vesting and a 1-year cliff. In PE with majority control, the equivalent structure is often phantom equity or sweetened management shares, with a revaluation mechanism at exit indexed to the fund's performance.
Component 4: Exit Bonus or Carry Participation
The exit bonus aligns the CRO with the MOIC realized by the fund, beyond what their individual equity carries. It's particularly useful in PE structures where CRO equity is limited but the fund wants to amplify alignment at exit. Typically, it's calibrated as a percentage of the MOIC uplift above a hurdle (for example, 0.5% of the value created above 2x MOIC), capped at an absolute ceiling to avoid surprises in the event of an exceptional exit.
| Component | Function | Relative Weight in Total Package | Horizon |
|---|---|---|---|
| Base salary | Opportunity cost coverage | 25-35% | Annual |
| Annual variable | Performance rhythm | 20-30% | Annual |
| Equity (true/phantom) | Holding-period alignment | 25-40% | 4-year vesting |
| Exit bonus | Exit amplification | 10-20% | Event-based |
The Ratios That Don't Lie
Add up the components and the total package for a CRO in a PE/VC-backed B2B scale-up typically falls in a range of €400k to €800k annual cash-equivalent (based on a 3x MOIC exit amortized over 4 years). Deviations above this range (beyond €1M annual cash-equivalent) are justified in pre-IPO Growth-stage portfolio companies. Deviations below it (under €350k) produce near-systematic turnover within the first 18 months.
Benchmarks by Stage in France (Series A to Growth)
The benchmarks below correspond to the ranges observed through our diagnostics and the French PE/VC B2B OP network. They are expressed in gross annual terms for base and variable, in fully diluted percentage for equity, and in ratio logic for the exit bonus.
Stage A: €5 to 15M ARR (Transition CRO)
At this stage, the portfolio company is moving beyond founder-led selling and installing its first structuring CRO. The target profile is not the most expensive on the market, and the package should reflect a player-coach posture more than a pure leadership posture.
| Component | Range | Comment |
|---|---|---|
| Base salary | €140-170k | €150k median on the segment |
| Annual variable | 80-100% of base | €130k OTE, 60% revenue / 40% strategic tilt |
| Equity (BSPCE) | 1.5% to 2.5% FD | 1-year cliff, 4-year vesting, double trigger |
| Exit bonus | Rare at this stage | Simplified structure, equity carries alignment |
| OTE package | €270-300k cash | Excluding equity |
Stage B: €15 to 30M ARR (Junior Scaler CRO)
The machine is running, PMF is established, and the CRO must scale without breaking things. The package moves closer to European scale-up standards.
| Component | Range | Comment |
|---|---|---|
| Base salary | €170-200k | €185k median |
| Annual variable | 90-110% of base | €180k OTE, 50/50 revenue/strategic |
| Equity | 1.0% to 1.8% FD | Still 1-year cliff, 4-year vesting |
| Exit bonus | Optional | If PE majority, 0.3-0.5% MOIC uplift above 2x |
| OTE package | €350-400k cash | Excluding equity |
Stage C: €30 to 50M ARR (Senior Scaler CRO)
The target profile has already been through a scale-up at a similar stage. The package incorporates a premium for maturity and track record.
| Component | Range | Comment |
|---|---|---|
| Base salary | €200-230k | €210k median |
| Annual variable | 100-120% of base | €230k OTE, balanced 50/50 |
| Equity | 0.7% to 1.3% FD | Refresh at 24 months common |
| Exit bonus | Standard in PE | 0.5-0.8% MOIC uplift, cap at €3-5M |
| OTE package | €430-480k cash | Excluding equity |
Growth Stage: €50M+ ARR (Optimizer CRO)
At this stage, the package incorporates a pre-IPO dimension if the trajectory allows it. Equity is often expressed as stock options or RSUs rather than BSPCE.
| Component | Range | Comment |
|---|---|---|
| Base salary | €220-280k | €240k median |
| Annual variable | 100-120% of base | €260k OTE, regional segmentation possible |
| Equity | 0.5% to 1.0% FD | Stock options or RSUs depending on stage |
| Exit bonus | Calibrated to IPO trajectory | Can convert into a liquidity event bonus |
| OTE package | €480-560k cash | Excluding equity |
The CRO/CEO Ratio Rule
Across all stages, CRO equity should sit between 30% and 55% of the founder CEO's. Below that, the CRO doesn't have enough alignment. Above it, the founder's relative dilution creates a structural tension that gets paid at exit.
PE vs VC: Two Pay Plan Philosophies
The difference between a CRO pay plan in a majority-PE context and one in a minority-VC context is structural, not cosmetic. The OP who mixes the two logics builds inconsistent packages that create problems at exit.
Minority VC Logic
The VC fund typically holds 20 to 40% of the capital and doesn't control the exit. CRO equity is true equity (BSPCE or AGA in France), it dilutes with subsequent rounds, and it appreciates with the valuation of each raise. The exit bonus is rare because the cap table structure already carries the alignment. The annual variable follows a classic ARR plus strategic metrics plan, paid in cash. The overall logic is long-term alignment with the company's trajectory, not with the profitability of a specific fund.
Majority PE Logic
The PE fund typically holds 60 to 90% of the capital and controls the exit. CRO equity can take several forms: classic true equity, a dedicated management package (MEP in France, sweet equity in the UK), phantom shares indexed to the fund's valuation at exit. The exit bonus is standard and often more structuring than the equity itself. The overall logic is alignment with the fund's MOIC, with particular attention to exit scenarios (trade sale, IPO, secondary LBO).
The Pitfalls of Mixing Logics
Mixing classic VC true equity with a PE exit bonus indexed to MOIC often produces a double alignment that, at exit, gives the CRO a disproportionate windfall. Conversely, installing PE phantom equity in a VC portfolio company creates a CRO who holds no actual equity stake but communicates as if they did, with the symbolic problems that follow. The OP must choose the dominant philosophy and build the package consistently with it.
| Dimension | Minority VC Logic | Majority PE Logic |
|---|---|---|
| Equity nature | True equity (BSPCE, AGA) | Phantom shares, MEP, sweet equity |
| Equity weight | 0.8-2.5% FD | 0.5-1.5% FD |
| Exit bonus | Rare or modest | Standard, structuring |
| Annual variable | Classic cash | Cash + potential deferred |
| Alignment horizon | Company trajectory | Fund MOIC |
| Exit control | CEO/board | Fund |
Evaluez votre maturite sur les 8 piliers en 2 minutes. Score instantane, gratuit.
Faire le quiz gratuit →Designing the Annual Variable
The annual variable is the component most often poorly designed. The three classic mistakes are: treating the CRO like a senior AE with a commission, indexing the variable solely on ARR without a quality metric, and paying quarterly without a clawback mechanism.
The 50/50 Split Between Revenue and Strategic
A robust design balances two categories of KPI. The first half of the variable is indexed to revenue metrics: net new ARR, bookings, NRR, logo retention. The second half is indexed to strategic metrics: sales team hiring, RevOps installation, forecast quality, upskilling middle managers. The 50/50 ratio protects against excesses in both directions: a CRO who does nothing but chase deals at the expense of building, or a CRO who builds without delivering revenue.
Choosing Revenue Metrics
Avoid metrics that can be gamed in the short term. Gross bookings incentivize signing fragile contracts. Net new ARR without NRR lets retention regressions slip through. A sound basket of revenue KPIs includes at least three metrics: net new ARR (growth), NRR (quality), logo retention or churn rate (stability). The detail of these metrics is worked out with the CFO and should go through a deal desk to avoid disputes at year-end.
Choosing Strategic Metrics
Strategic metrics must be measurable and documentable, otherwise they become subjective and a source of friction. Calibrated examples: full staffing of the sales team against plan target (yes/no), new AE ramp to 80% of quota within 6 months (percentage achieved), quarter-over-quarter forecast accuracy (gap in points), NRR target (percentage achieved), revenue team engagement score on the annual survey. Each metric must have a documented measurement method at the time the pay plan is signed.
Payment Cadence and Clawback
The variable is typically paid quarterly for revenue metrics (80% of the quarterly target) and annually for strategic metrics (post-annual-board evaluation). A clawback mechanism must exist on bookings for deals that churn within 12 months: the CRO should not receive a variable payout on a deal that falls apart 6 months later. In practice, a portion (20 to 30%) of the revenue variable is deferred 12 months and paid if the underlying deals are still active.
| Variable Dimension | Weight | Metric | Payment Frequency |
|---|---|---|---|
| Net new ARR | 25% | Annual growth | Quarterly, 30% deferred |
| NRR | 15% | 110%+ target achievement | Annual |
| Logo retention | 10% | Churn target achievement | Annual |
| Team staffing | 15% | Plan vs. actual | Annual |
| Forecast accuracy | 10% | Average quarterly gap | Annual |
| Management quality | 15% | AE ramp, manager scores | Annual |
| Strategic projects | 10% | VC plan deliverables | Annual |
Designing Equity
CRO equity is the component with the longest commitment and the one most poorly negotiated. The classic mistakes are structural and hard to correct after the fact.
Pool Size and Target Allocation
A pool dedicated to the management team is typically 10 to 15% of fully diluted capital in a French VC-backed B2B scale-up. The CRO draws 1 to 2.5% from it depending on stage. The pool must be sized generously enough to cover the CRO, the VP Engineering, the CFO, the VP Marketing, and the VPs who follow. An undersized pool forces special dilution rounds that create board tension with every hire.
Cliff and Vesting
Robust standard: 1-year cliff, 4-year vesting, monthly after the cliff. The cliff protects the portfolio company against a CRO who leaves within 12 months while taking a share of the equity. The 4-year vesting aligns with a fund's typical holding period. Any deviation from this standard (no cliff, 3-year vesting, early acceleration) must be documented and justified to the investment committee.
Acceleration at Change of Control
The acceleration clause determines what happens at exit. Two structures exist. Single trigger automatically accelerates equity at the moment of change of control, regardless of what happens to the CRO post-exit. Double trigger only accelerates if the CRO is terminated within X months following the exit (typically 12 months). The recommended OP standard is double trigger: it protects the CRO against a post-deal termination but doesn't hand them a windfall if they carry on normally in their role.
Refresh Grants
Initial equity mechanically depletes after 2 to 3 years of vesting. A CRO who has vested 60% of their equity and still sees 2 years of holding period ahead no longer has the same alignment. The refresh grant typically occurs at month 24 post-hire, with an additional allocation of 0.3 to 0.8% vesting over 4 years from the refresh date. This is a discipline to build into the value creation plan, not a favor to negotiate in reaction to a threatened departure.
French BSPCE, AGA, and Stock Option Specifics
In France, three instruments coexist. BSPCE (bons de souscription de parts de créateur d'entreprise, or founder warrants) are reserved for eligible companies and offer favorable tax treatment. AGA (actions gratuites, or free shares) impose a minimum vesting period (typically 1 year) and a holding period after vesting. Classic stock options are more flexible but less attractive tax-wise. The choice of instrument depends on the company's structure, its stage, and the candidate's preferences. The OP must work with the portfolio company's legal counsel to validate eligibility and the tax structure before finalizing the package.
| Equity Element | Robust Standard | Acceptable Variant | Red Flag |
|---|---|---|---|
| Cliff | 1 year | 6 months (if pre-closing signed) | 0 cliff |
| Vesting | 4 years monthly | 3 years if senior C-level CRO | < 3 years |
| Acceleration | Double trigger 12 months | Double trigger 24 months | Automatic single trigger |
| Refresh | M24, 0.3-0.8% FD | M36 if Growth stage | No documented refresh |
| French instrument | BSPCE if eligible | AGA or stock options | Non-qualifying stock options |
Exit Bonus Mechanics
The exit bonus is the component that demands the most rigor because it materializes at the most sensitive moment of the holding cycle: the exit.
The Logic of the MOIC Uplift-Indexed Bonus
A robust design indexes the exit bonus to the value created above a hurdle. Example: 0.5% of the uplift value above 2x MOIC, capped at €3M. If the fund realizes 1.5x MOIC, the exit bonus is zero. If the fund realizes 3x, the bonus is calculated on the delta between 3x and 2x. If the fund realizes 6x, the bonus is capped at the ceiling. This structure aligns the CRO with a successful exit without creating a windfall on normal trajectories.
The Absolute Cap to Avoid Surprises
The absolute cap is non-negotiable on the OP side. An uncapped structure produces indefensible outcomes in the event of an exceptional exit: a CRO who joined the portfolio company at €20M ARR and pockets a €15M bonus on an 8x MOIC exit creates an internal political problem for the fund and an unreasonable signal for future hires. The cap must be set as an absolute figure (for example, €3 to 5M depending on stage) and documented in the package's term sheet.
The Relationship with Individual Equity
The exit bonus is not a duplicate of equity, it's a complement. If the CRO already has 1.5% FD, the exit bonus should stay modest (0.3 to 0.5% MOIC uplift). If the CRO has 0.5% FD in a majority PE control context, the exit bonus can be more structuring (0.8 to 1.2% MOIC uplift) because it carries the exit alignment.
Exit Scenarios to Model
The OP must model the total package under three scenarios before signing: downside (1.5x MOIC, typically a forced secondary LBO), base (3x MOIC, normal exit), upside (5x+ MOIC, exceptional exit or IPO). The package must be reasonable under all three scenarios. If the downside produces total 4-year compensation below €1.5M, the package is probably undercalibrated. If the upside produces an exit bonus above 15% of the value created, the structure is unbalanced.
| Exit Scenario | MOIC | CRO Equity Cash-Out | Exit Bonus | Total 4-Year Package |
|---|---|---|---|---|
| Downside | 1.5x | Modest (low valuation) | Zero (below hurdle) | Base + variable only |
| Base | 3x | Significant | Activated, partial | €2-4M cash-equivalent |
| Upside | 5x+ | Strong | Capped at ceiling | €5-8M cash-equivalent |
French Tax and Social Charge Specifics
The CRO pay plan in France is built within a specific tax and social-charge environment that changes the cost for the portfolio company and the net for the candidate.
Employer Social Charges
Base salary and cash variable carry employer social charges of 40 to 45% in France, versus 15 to 25% in other jurisdictions. A €400k OTE package represents a total annual cost to the portfolio company of €560 to 580k. This arithmetic must be made explicit in the budget brief sent to the CEO: a UK or US benchmark isn't directly transposable.
BSPCE Treatment
BSPCE benefit from favorable tax treatment for the beneficiary (capital gain on disposal taxed at the flat 30% rate after 3 years of holding, with an enhanced allowance in certain cases). On the company side, their issuance generates no social charge at the time of grant. It's the priority instrument for eligible companies (under 15 years old, capital held mostly by individuals under certain conditions).
AGA Treatment
AGA (free shares) are subject to a specific 20% employer contribution on the vested value, which significantly increases the cost for the company. They also impose a minimum 1-year vesting period and a total holding period of at least 2 years. On the beneficiary side, they are taxed as capital gains on securities upon disposal.
MEP Management Package
The management package (MEP) is a structure for management's personal investment in a dedicated vehicle that invests alongside the fund. It's common in majority PE LBOs. It enables strong alignment with the fund but requires an initial cash investment from the CRO (typically €50 to 150k) and a legal complexity that isn't justified on smaller portfolio companies.
| Instrument | Employer Charge | Beneficiary Taxation | Typical Use |
|---|---|---|---|
| Salary + cash bonus | 40-45% | Marginal income tax rate | Base of the package |
| BSPCE | 0% | 30% flat tax after 3 years | Stage A-C, eligible company |
| AGA | 20% contribution | Capital gain on securities | Growth stage, non-BSPCE company |
| Stock options | Varies by regime | Capital gain or salary | Rare in French scale-ups |
| MEP | N/A (personal investment) | Capital gain | Majority PE LBO only |
Pay Plan Review and Refresh Cadence
A pay plan is not a contract frozen for 4 years. It is revised on an annual cadence with a structured discipline.
The Annual Post-Board Review
Each year, ideally within 30 days of the annual board meeting, the CRO pay plan is reviewed along three dimensions. Base salary is indexed to the evolution of the portfolio benchmark and to the portfolio company's ARR progress (crossing a milestone can justify a revaluation). The annual variable is recalibrated on the board-approved plan for the following year. Metrics are adjusted based on new priorities. Equity isn't reviewed annually, but the need for a refresh grant arises at month 24 and is decided at that point.
The Refresh Grant and Its Logic
The refresh grant typically occurs at month 24 post-hire, when 50% of the initial equity has vested and the CRO starts seeing the horizon approach. The refresh amount is calibrated based on observed performance and the retention need over the following 3 years. An indicative grid: 0.3% FD if performance is on plan, 0.5% for moderate outperformance, 0.8% for strong outperformance with a risk of departure to a competitor. The refresh is decided by the investment committee, not by the CEO alone.
Off-Cycle Triggers
Certain events trigger a review outside the annual cycle. A documented competing offer presented by the CRO to the CEO triggers a retention discussion within 14 days. A significant ARR milestone crossing (moving from €15 to 30M) often justifies a base revaluation and a potential early refresh. Repeated underperformance over two consecutive fiscal years triggers a conversation about the variable, or even about continuing the mandate.
The Living Document and Its Documentation
The pay plan must exist as a written document, signed by the CRO and the CEO, countersigned by the chair of the compensation committee, and archived at the portfolio company level. It must be updated at every annual review with a dated version. This discipline protects the relationship against the memory-based misunderstandings that always surface after 2 to 3 years.
Pay Plans That Create Value vs. Pay Plans That Destroy It
Observing CRO pay plans across several years and several portfolio companies reveals recurring patterns of success and failure.
Patterns That Create Value
Packages that have carried high-performing CROs over 3 to 5 years share several characteristics. They have an annual variable balanced 50/50 revenue/strategic that avoids the deal-chasing drift. They have significant equity that's still consistent with the CEO ratio (30-55% of the CEO's). They build in an early refresh grant at month 24. They have a capped exit bonus that aligns without distorting. They document variable metrics precisely to avoid annual disputes. They are reviewed every year with strict calendar discipline.
Patterns That Destroy Value
Conversely, certain patterns recur regularly in pay plans that led to CRO departures or exit tensions. A 100% revenue variable that produced a CRO focused on deals at the expense of the team. Equity with single trigger acceleration that created a windfall at exit deemed unreasonable by the committee. An uncapped exit bonus that produced a €12M payout on an exceptional exit. A pay plan never reviewed that ended up disconnected from the market benchmark and led to the CRO's departure at M+30. An overcalibrated base that neutralized long-term motivation.
The OP's Role in Both Cases
In pay plans that create value, the OP brought the benchmark, challenged the initial requests, structured the annual review, and prepared the refresh grant in advance. In pay plans that destroy value, the OP merely rubber-stamped what the CEO and the search firm had negotiated, without projecting exit scenarios and without installing review discipline.
Communicating the Pay Plan to the Candidate
How the pay plan is presented to the candidate matters as much as its content.
Documented Transparency
The pay plan must be presented to the candidate as a written document structured around the four components, with the range for each component, the variable's metrics, the equity mechanics, and the modeled exit scenarios. Full upfront transparency avoids later misunderstandings and filters out candidates who would have accepted based on a false understanding.
Consistency with the Market Benchmark
A senior candidate will check the package against the market benchmark. A package that deviates significantly from the benchmark must be explicitly justified: why lower (early stage, larger equity share), why higher (cross-functional scope, market technicality). A poorly justified package creates tension right from the negotiation.
The CEO's Role vs. the OP's Role
The CEO remains the lead negotiator. The OP plays the role of benchmark expert who steps in behind the scenes to validate consistency, explain the equity and exit bonus structures, and answer the candidate's technical questions on capital-markets mechanics. The OP is never alone in the negotiation: they protect the CEO, who remains the CRO's manager after hiring.
OP Roadmap: Building the CRO Pay Plan in 6 Steps
| Step | Timing | Deliverables | Owner |
|---|---|---|---|
| 1. Portfolio benchmark | Day -30 before offer | 4-component grid by stage, median + range | OP |
| 2. CEO framing | Day -21 | Alignment on total envelope and PE vs. VC philosophy | CEO + OP |
| 3. Draft package | Day -14 | Document with 4 components priced + variable metrics | OP + CFO |
| 4. Exit scenario modeling | Day -10 | 3 documented scenarios (downside, base, upside) | OP |
| 5. Negotiation with candidate | Day -7 to Day | CEO in the lead, OP behind the scenes | CEO |
| 6. Final documentation | Day +7 | Signed contract, equity term sheet, review calendar | Legal counsel |
Further Resources
- 100-Day Plan for Portfolio Companies: OP Method
- Hiring a Portfolio Company CRO: OP Criteria
- Portfolio Benchmark: Revenue Method
- Challenging a CEO: Operating Partner Grid
- Value Creation Plan: The Revenue Component
- Hiring a VP Sales: The CRO's Criteria
- Sales Pay Plan: Structuring Compensation
- CSM Pay Plan: Compensation and Retention
- Top Performer Dependency: A Structural Risk
- The CRO's 100-Day Plan: Taking the Role
- Sales Forecasting: Precision and Reliability
- NRR: The Metric That Sums Up Revenue
- B2B Revenue KPIs: Metrics for the CEO
- ACROSS Methodology
Sources Cited
- Our Revenue Health Score diagnostics conducted with B2B scale-ups (proprietary ACROSS benchmarks on base, variable, equity, and CRO exit bonus in France, 2024-2026).
- Jack Welch, Winning (HarperBusiness) on the role of compensation as a strategic communication tool.
Article written by Charles-Alexandre Peretz, founder of ACROSS Insight. Last updated: September 11, 2026.